GEN Exclusives

More »
Readers Comments Back to Item »

The Global Outlook for Regenerative Medicine and Stem Cells

1 Readers' Comments

Posted by: Editor: http//stemcelldigest.net

08/25/2009

The stem cell sector we cover, consisting of twenty companies all traded on U.S. exchanges, has shown the ability to raise capital even in the difficult environment of the last twelve months. I agree about the patent issue and the confusion that abounds there. Legal and regulatory harmonization is probably a long way off and will follow rather than lead the development of applicable therapies.

  • Click here to Login or to Register for free.

    You will be taken back to your selected item after Login/Registration.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?